Andrew C. G. Uprichard

Andrew C. G. Uprichard

Plus aucun poste en cours

66 ans
Health Technology
Consumer Services

Profil

Andrew C.
G.
Uprichard
is President and Head-Research and Development of EPIX Pharmaceuticals, Inc., which he joined in July 2004.
He served as President and Chief Operating Officer of EPIX Pharmaceuticals.
From 2002 to 2003, Dr. Uprichard served as Chief Operating Officer of ArQule, Inc. and from 2000 to 2002 Curis, Inc. He spent 11 years with Parke-Davis Pharmaceutical Research, a division of Warner-Lambert and served as Vice President-Drug Development from 1997 to 2000 and Senior Director of Cardiovascular Pharmacology from 1994 to 1997.
From 1989 to 1994, Dr. Uprichard held various oversight positions in Cardiovascular Clinical Development.
In the late 1980s, he was a Cardiology and Postdoctoral Fellow at the University of Michigan Medical School.
Dr. Uprichard is a Fellow of the Royal College of Physicians of Edinburgh, the Faculty of Pharmaceutical Medicine and the American College of Physicians.
He received MB, ChB and MD degrees from the University of Edinburgh, Scotland.

Anciens postes connus de Andrew C. G. Uprichard

SociétésPosteFin
President 21/05/2008
ARQULE, INC. Directeur des opérations 01/01/2003
CURIS, INC. Directeur des opérations 01/01/2002
President -
Corporate Officer/Principal -
Voir l'expérience en détail de Andrew C. G. Uprichard

Formation de Andrew C. G. Uprichard

The University of Edinburgh Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Andrew C. G. Uprichard

Relations

35

Relations au 1er degré

6

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
CURIS, INC.

Health Technology

Entreprise privées4

Health Technology

Health Technology

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Andrew C. G. Uprichard
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT